Sensitization of human colon cancer cells to sodium butyrate-induced apoptosis by modulation of sphingosine kinase 2 and protein kinase D

Experimental Cell Research

Volumn 318, Issue 1, 2012, Pages 43-52

  Xiao, Min ^a   Liu, Yungang ^a   Zou, Fei ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Colon cancer; Protein kinase D; Sodium butyrate; Sphingosine kinase 2

Indexed keywords

BUTYRIC ACID; CELL PROTEIN; PROTEIN KINASE D; SMALL INTERFERING RNA; SPHINGOSINE KINASE 2;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CELL STRAIN HCT116; COLON CANCER; CYTOPLASM; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 81355132801     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.10.006     Document Type: Article

References (24)

1. Kawamori T., Kaneshiro T., Okumura M., Maalouf S., Uflacker A., Bielawski J., Hannun Y.A., Obeid L.M. Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J. 2009, 23:405-414.
2. Spiegel S., Milstein S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 2003, 4:397-407.
3. Milstien S., Spiegel S. Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics. Cancer Cell 2006, 9:148-150.
4. Kawamori T., Osta W., Johnson K.R., Pettus B.J., Bielawski J., Tanaka T., Wargovich M.J., Reddy B.S., Hannun Y.A., Obeid L.M., Zhou D.H. Sphingosine kinase 1 is up-regulated in colon carcinogenesis. FASEB J. 2006, 20:386-388.
5. Johnson K.R., Becker K.P., Facchinetti M.M., Hannun Y.A., Obeid L.M. PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane, extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). J. Biol. Chem. 2002, 277:35257-35262.
6. Pitson S.M., Moretti P.A., Zebol J.R., Lynn H.E., Xia P., Vadas M.A., Wattenberg B.W. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J. 2003, 22:5491-5500.
7. Pitson S.M., Xia P., Leclercq T.M., Moretti P.A., Zebol J.R., Lynn H.E., Wattenberg B.W., Vadas M.A. Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signaling. J. Exp. Med. 2005, 201:49-54.
8. Okada T., Ding G., Sonoda H., Kajimoto T., Haga Y., Khosrowbeygi A., Gao S., Miwa N., Jahangeer S., Nakamura S. Involvement of N-terminal-extended form of sphingosine kinase 2 in serum-dependent regulation of cell proliferation and apoptosis. J. Biol. Chem. 2005, 280:36318-36325.
9. Liu H., Toman R.E., Goparaju S.K., Maceyka M., Nava V.E., Sankala H., Payne S.G., Bektas M., Ishii I., Chun J., Milstien S., Spiegel S. Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J. Biol. Chem. 2003, 278:40330-40336.
10. Igarashi N., Okada T., Hayashi S., Fujita T., Jahangeer S., Nakamura S. Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J. Biol. Chem. 2003, 278:46832-46839.
11. Min J., Mesika A., Sivaguru M., Van Veldhoven P.P., Alexander H., Futerman A.H., Alexander S. (Dihydro)ceramide synthase 1 regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by sphingosine kinase 1. Mol. Cancer Res. 2007, 5:801-812.
12. Van Brocklyn J.R., Jackson C.A., Pearl D.K., Kotur M.S., Snyder P.J., Prior T.W. Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J. Neuropathol. Exp. Neurol. 2005, 64:695-705.
13. Hague A., Manning A.M., Hanlon K.A., Huschtscha L.I., Hart D., Paraskeva C. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int. J. Cancer 1993, 55:498-505.
14. Marks P.A., Rifkind R.A., Richon V.M., Breslow R., Miller T., Kelly W.K. Histone deacetylases and cancer: causes and therapies. Nat. Rev. Cancer 2001, 1:194-202.
15. Schwartz B., Avivi-Green C., Polak-Charcon S. Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells. Mol. Cell. Biochem. 1998, 188:21-30.
16. Saito A., Yamashita T., Mariko Y., Nosaka Y., Tsuchiya K., Ando T., Suzuki T., Tsuruo T., Nakanishi O. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc. Natl. Acad. Sci. 1999, 96:4592-4597.
17. Weis K. Importins and exportins: how to get in and out of the nucleus. Trends Biochem. Sci. 1998, 23:185-189.
18. Ding G., Sonoda H., Yu H., Kajimoto T., Goparaju S.K., Jahangeer S., Okada T., Nakamura S. Protein kinase D-mediated phosphorylation and nuclear export of sphingosine kinase 2. J. Biol. Chem. 2007, 282:27493-27502.
19. Hait N.C., Bellamy A., Milstien S., Kordula T., Spiegel S. Sphingosine kinase type 2 activation by ERK-mediated phosphorylation. J. Biol. Chem. 2007, 282:12058-12065.
20. Pchejetski D., Golzio M., Bonhoure E., Calvet C., Doumerc N., Garcia V., Mazerolles C., Rischmann P., Teissie J., Malavaud B., Cuvillier O. Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res. 2005, 65:11667-11675.
21. Bektas M., Jolly P.S., Müller C., Eberle J., Spiegel S., Geilen C.C. Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression. Oncogene 2005, 24:178-187.
22. Song L., Xiong H., Li J., Liao W., Wu J., Li M. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer. Clin. Cancer Res. 2011, 17:1839-1849.
23. Akao Y., Banno Y., Nakagawa Y., Hasegawa N., Kim T.J., Murate T., Lgarashi Y., Nozawa Y. High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation. Biochem. Biophys. Res. Commun. 2006, 342:1284-1290.
24. Bandyopadhyay D., Mishra A., Medrano E.E. Overexpression of histone deacetylase 1 confers resistance to sodium butyrate-mediated apoptosis in melanoma cells through a p53-mediated pathway. Cancer Res. 2004, 64:7706-7710.